Yakob Liawatidewi - 04 Jun 2023 Form 4 Insider Report for Amphastar Pharmaceuticals, Inc. (AMPH)

Role
EVP Corp Admin Center, Director
Signature
/s/ Eva Wen, by power of attorney
Issuer symbol
AMPH
Transactions as of
04 Jun 2023
Net transactions value
-$17,653
Form type
4
Filing time
06 Jun 2023, 18:49:04 UTC
Previous filing
14 Apr 2023
Next filing
29 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMPH Common Stock Tax liability $17,653 -378 -0.54% $46.70 69,669 04 Jun 2023 Direct F1, F2
holding AMPH Common Stock 2,459 04 Jun 2023 See footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units, or RSUs.
F2 Includes 832 shares acquired under the Issuer's 2014 Employee Stock Purchase Plan on May 31, 2023.
F3 The reported shares are held of record by the Yakob and Sunmoon Trust dated July 25, 2013 for which the reporting person serves as a trustee.